PPPiyatida Prasertvit

Piyatida Prasertvit

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Piyatida Prasertvit has a total of 2 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Nevirapine patch testing in Thai human immunodeficiency virus infected patients with nevirapine drug hypersensitivity

    by Piyatida Prasertvit, Angkana Chareonyingwattana, Penpun Wattanakrai

    Summary: Background: Antiretroviral drug hypersensitivity in HIV patients is common. Publications have shown that Abacavir (ABC) patch testing is useful in confirming ABC hypersensitivity in 24–50% of cases with a 100% sensitivity of HLA‐B*5701 in patch test positive cases. However, Nevirapine (NVP) patch testing has not been reported.Objectives: (1) To evaluate the usefulness and safety of NVP patch testing in Thai HIV patients with NVP hypersensitivity. (2) To assess the correlation of positive patch tests with HLA‐B*3505.Patients and methods: Patients were classified into two groups: (1) study group of 20 HIV NVP hypersensitivity patients and (2) control group of 15 volunteers without NVP hypersensitivity. Both groups were patch tested with purified and commercialized form of NVP in various vehicles.Results: Two HIV patients with NVP hypersensitivity were patch test positive. All controls tested negative. Three HIV patients were positive for HLA‐B*3505 and the two patients with positive patch testing were both HLA‐B*3505 positive.Conclusions: NVP patch testing in Thai HIV patients is safe and can be used to help confirm the association between NVP and hypersensitivity skin reactions. NVP patch test results significantly correlated with HLA‐B*3505. The sensitivity of HLA‐B*3505 for positive patch test was 100%.